Posted on

[54] also reported that ranibizumab was far better in inhibiting endothelial cell proliferation than bevacizumab moderately, even though within an acute assay bevacizumab better inhibited VEGF-stimulated MAPK and VEGFR2 phosphorylation in individual microvascular endothelial cells

[54] also reported that ranibizumab was far better in inhibiting endothelial cell proliferation than bevacizumab moderately, even though within an…

[54] also reported that ranibizumab was far better in inhibiting endothelial cell proliferation than bevacizumab moderately, even though within an acute assay bevacizumab better inhibited VEGF-stimulated MAPK and VEGFR2 phosphorylation in individual microvascular endothelial cells Read More